Nevertheless, another laboratory showed that GABARAPL1 was up-regulated in TNBC cell lines and tissue, and that a high expression in this gene was associated with shorter overall survival [31], suggesting that the analysis of mRNA expression using BC molecular subtypes could lead to significantly different conclusions, compared to a non-classified report, thus proving the heterogeneity of BC. This evidence concerns the gene GABARAPL1 and breast cancer.